Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

HJB and MabSpace Merge to Combine Bioprocessing and mAb Discovery Skills

publication date: Jan 2, 2019

HJB, a China based-bioprocessing specialist, will merge with MabSpace of Suzhou, a discovery/development biotech, to form Transcenta Holding. The new company will have a pipeline of 10 innovative molecules. It plans to use HJB's capabilities to shorten the timeline from target to BLA, using its next-gen Hangzhou GMP facility to support development of in-house and partnered molecules. Dr. Xueming Qian, former MabSpace Founder, Chairman and CEO, will be CEO of Transcenta, while Dr. Jonathan Yining Zhao, Co-founder and CEO of HJB, will be its Executive Chairman. Financial details were not disclosed. More details....

Share this with colleagues:

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021